Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
51389-5 Views^W Tl-201 IV Find Breast Pt Doc NM   ACTIVE NM Breast Views W Tl-201 IV   MIN DefinitionDescription                   RAD   51389-5   NM     Both       0 NM Brst Views W Tl-201 IV       N   201TI; Brst; Document; Films; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; Scan; Thallium 201; Thallous; T-I201; TL-201; View; VWS 2.64 2.22                     The scale has been changed from "Nar" to "Doc" to fit with the CDA model.; Method of "Radnuc" was changed to "NM". The LOINC/RadLex Committee agreed to use a subset of the two-letter DICOM modality codes as the primary modality identifier. 0
5139-1 Echovirus 19 Ab Titr Ser Pt SemiQn Comp fix   ACTIVE Echovirus 19 Ab [Titer] in Serum by Complement fixation   MAJ DefinitionDescription     titer             MICRO   5139-1   Comp fix     Both       0 ECV19 Ab Titr Ser CF       Y   ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; Dilution factor; Dilution Factor (Titer); Echo; Echo virus; Echovirus type 19; ECV; ECV19; EV; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 1               {titer}       0
51390-3 Views AP & lateral Find Abdomen Pt Nar XR   DEPRECATED Deprecated Abdomen X-ray AP & lateral   DEL DefinitionDescription                   RAD   51390-3   XR     Both       0 Deprecated Abd XR AP+Lat       N   Abd; Abdo; Abdomen+; Abdominal; Anterio-Posterior; Anteroposterior; AP+Lat; Films; Finding; Findings; Imaging; Lat; Narrative; Plain Films; Point in time; Rad; RADIOLOGY; Random; Report; View; Views & AP KUB; Views (AP; Views AP KUB & lateral; Views AP+lateral; Views+AP; VWS; Xray; X-ray 2.36 2.22       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
51391-1 Guidance for transjugular placement of transjugular intrahepatic portosystemic shunt Find Abdomen>Portal vein+Hepatic vein Pt Doc RF.angio   ACTIVE RFA Guidance for placement of TIPS of Portal vein and Hepatic vein   MIN DefinitionDescription       CLINICAL HISTORY: GI BLEED REPORT: ADDITIONAL CLINICAL INFORMATION: BLEEDING, GASTRIC VARICES. NOT AMENABLE TO ENDOSCOPIC THERAPY. PATIENT HEMODYNAMICALLY UNSTABLE. TECHNIQUE: Written informed consent was obtained from the patient's family. The patient was placed supine. The right internal jugular vein was accessed with a 21 gauge need. A Kumpe catheter and hydrophilic guide were used to select the right hepatic vein. A 5 French balloon occlusion catheter was advanced to the terminates of the vein and the balloon inflated. C2 wedged hepatic venography was performed opacifying the right portal vein. The vein was accessed with a Colapinto needle. The needle was exchanged for a catheter. Through the 9 French sheath placed in the right atrium, dual pressures were obtained. The portal pressure was measured at 25 mmHg and the systemic pressure at 8 mmHg for a portal systemic gradient of 17 mmHg. Angiography was performed revealing three large caliber para-perigastric varices. Other smaller varices were identified. At this point, the intrahepatic tract was dilated to 6 mm and a 10 mm x 6 mm Prot'e9g'e9 stent deployed from the right portal vein toward the hepatic vein. The stent was short and a second 10 mm x 4 cm Prot'e9g'e9 stent placed to the hepatic vein. This was dilated to 9 mm. Repeat portosystemic gradient measurement was 14 mmHg. Large caliber varices filled . The stent was then dilated to 10 mm. There was persistent filling of the large caliber varices. At this point, a Davis catheter and hydrophilic guide wire were used to select the larger varices. A total of three varices were selected and embolized with metallic coils. Repeat angiography confirmed no persistent filling of those varices. Repeat angiography of the TIPS shunt confirmed patency, but a stenosis near the hepatic venous end. This was dilated to 10 mm. Repeat angiography from the portal vein revealed a widely patent stent and repeat pressures were measured at 19 mmHg portal and 13 mmHg systemic for a portosystemic gradient of 6 mmHg. At this point, catheters were removed a triple lumen left in place in the SVC. PROCEDURES PERFORMED: 1. TIPS creation. 2. Coil embolization gastric varices. 3. Triple lumen catheter placement. IMPRESSION: 1. TIPS SHUNT CREATION AS DESCRIBED WITH RESULTANT DECREASE IN PORTOSYSTEMIC GRADIENT FROM 17 mmHg TO 6 mmHg. 2. COIL EMBOLIZATION OF GASTRIC VARICES AS DESCRIBED. 3. TRIPLE LUMEN CATHETER PLACEMENT.           RAD   51391-1   RF.angio     Both       0 RFA Guided Portal v+Hepatic v TIPS place       N   Abd; Abdo; Abdomen+; Abdominal; Cardio; Cardiology; Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Heart Disease; Hep v; Hep vein; Hepar; Imaging; Liver; Liver vein; Point in time; Portal v+Hepatic v; Portal+Hepatic v; PV; Rad; Radiology; Random; RFA; Shuntogm; Shuntogram; TIPS place; TIPSS; Ven; Venous 2.64 2.22                     The scale has been changed from "Nar" to "Doc" to fit with the CDA model.; Jan 2016 Changed System from "Portal vein+Hepatic vein" to "Abdomen>Portal vein+Hepatic vein" to conform with LOINC/RadLex unified model; Method of "XR.fluor.angio" was changed to "RF.angio". The LOINC/RadLex Committee agreed to use a subset of the two-letter DICOM modality codes as the primary modality identifier.; Added "transjugular" as approach for the "placement" action per LOINC/RadLex unified model 0
51392-9 Views Find Upper extremity.left>Wrist+Hand Pt Doc XR   ACTIVE XR Wrist - left and Hand - left Views   MIN DefinitionDescription                   RAD   51392-9   XR     Both       0 XR Wrist+Hand-L Views       N   Arm; Carpal bone; Carpal bones; Carpal bones and joint; Document; EXT; Extr-L; Films; Finding; Findings; Imaging; L; LT; LUE; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Rad; RADIOLOGY; Random; UE; UE-L; Up; Upper extremity; Upper extremity joint; View; VWS; Wrist+Hand-L; Wrist-L; Xray; X-ray 2.64 2.22                     The scale has been changed from "Nar" to "Doc" to fit with the CDA model.; Updated System from "Wrist.left+Hand.left" per LOINC/RadLex unified model 0
51393-7 Esophageal manometry study Find Esophagus Stdy Doc Manometry   ACTIVE Esophageal manometry study   NAM DefinitionDescription                   ENDO.GI   51393-7   Manometry     Both       0 Manometry study       N   Document; Esophageal; Finding; Findings; Gastro; Gastroenterology; GI; GI.ENDOSCOPY; Studies; Study; Study report; Sutdies 2.72 2.22                     Release 2.72: COMPONENT: Update naming convention for studies.; SCALE_TYP: Modeling consistency for studies.; 0
51394-5 Views Find Lower extremity.right>Ankle+Foot Pt Doc XR   ACTIVE XR Ankle and Foot - right Views   MIN DefinitionDescription                   RAD   51394-5   XR     Both       0 XR Ankle+Foot-R Views       N   Ankle+Foot-R; Ankle-R; Document; EXT; Extr-R; Films; Finding; Findings; Ft; Imaging; LE; Leg; LE-R; Low; Lower extremity; Lower extremity joint; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; R; Rad; RADIOLOGY; Random; RLE; RT; View; VWS; Xray; X-ray 2.64 2.22                     The scale has been changed from "Nar" to "Doc" to fit with the CDA model.; Updated System from "Ankle.right+Foot.right" to conform with LOINC/RadLex unified model 0
51395-2 Views Find Lower extremity.left>Ankle+Foot Pt Doc XR   ACTIVE XR Ankle and Foot - left Views   MIN DefinitionDescription                   RAD   51395-2   XR     Both       0 XR Ankle+Foot-L Views       N   Ankle+Foot-L; Ankle-L; Document; EXT; Extr-L; Films; Finding; Findings; Imaging; L; LE; Leg; LE-L; LLE; Low; Lower extremity; Lower extremity joint; LT; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Rad; Radiology; Random; View; VWS; Xray; X-ray 2.64 2.22                     The scale has been changed from "Nar" to "Doc" to fit with the CDA model.; Updated System from "Ankle.left+Foot.left" to conform with LOINC/RadLex unified model 0
51396-0 Cells.CD65w/Cells NFr Tiss Pt Qn     ACTIVE CD65w cells/cells in Tissue   NAM DefinitionDescription     %             CELLMARK   51396-0         Observation       0 CD65w Cells NFr Tiss       N   CD65w Cells; Cell; CELL MARKERS; Cellularity; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified 2.79 2.22               %     Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
51397-8 Cells.CD65w/Cells NFr CSF Pt Qn     ACTIVE CD65w cells/cells in Cerebral spinal fluid   NAM DefinitionDescription     %             CELLMARK   51397-8         Observation       0 CD65w Cells NFr CSF       N   CD65w Cells; Cell; CELL MARKERS; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid 2.79 2.22               %     Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
51398-6 Cells.CD65w/Cells NFr Bone mar Pt Qn     ACTIVE CD65w cells/cells in Bone marrow   NAM DefinitionDescription     %             CELLMARK   51398-6         Observation       0 CD65w Cells NFr Mar       N   BM; BON; Bone marrow; CD65w Cells; Cell; CELL MARKERS; Cellularity; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random 2.79 2.22               %     Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
51399-4 Cells.CD65w/Cells NFr Body fld Pt Qn     ACTIVE CD65w cells/cells in Body fluid   NAM DefinitionDescription     %             CELLMARK   51399-4         Observation       0 CD65w Cells NFr Fld       N   B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD65w Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random 2.79 2.22               %     Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
514-0 Trimethoprim Titr Isolate+Ser Pt SemiQn SBT   ACTIVE Trimethoprim [Susceptibility] by Serum bactericidal titer   MAJ DefinitionDescription     titer             ABXBACT   514-0   SBT     Observation       0 Trimethoprim Titr SBT           ANTIBIOTIC SUSCEPTIBILITIES; c202; c242; C62; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Polytrim; Primsol; Proloprim; Random; Sequence based typing; Serum; SERUM BACTERICIDAL TITER; Serum killing test; SmQn; SR; Titer; Titered; Titre; TMP; Trimeth; Trimpex; Ttr 2.75 1               {titer}       0
5140-9 Echovirus 3 Ab.Neut Titr Ser Pt SemiQn Neut   ACTIVE Echovirus 3 neutralizing antibody [Titer] in Serum by Neutralization test   MAJ DefinitionDescription     titer             MICRO   5140-9   Neut     Both       0 ECV3 NAb Titr Ser Nt       Y   ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); Echo; Echo virus; Echovirus type 3; ECV; ECV3; EV; ID; III; Infectious Disease; InfectiousDisease; Microbiology; NAb; NEUTRALIZATION; Neutralization test; NT; Point in time; Random; Serum; Serum virus neutralization; SmQn; SR; SVN; Titer; Titered; Titre; Ttr; Virus neutralization test; VNT 2.75 1               {titer}     Release 2.72: COMPONENT: Updated "Ab" to "Ab.Neut" since this test is detecting neutralizing antibodies.; 0
51400-0 Cells.CD65w/Cells NFr Bld Pt Qn     ACTIVE CD65w cells/cells in Blood   NAM DefinitionDescription     %             CELLMARK   51400-0         Observation       0 CD65w Cells NFr Bld       N   Blood; CD65w Cells; Cell; CELL MARKERS; Cellularity; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.79 2.22               %     Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
51401-8 Cells.CD81/Cells NFr Tiss Pt Qn     ACTIVE CD81 cells/cells in Tissue   NAM DefinitionDescription     %             CELLMARK   51401-8         Observation       0 CD81 Cells NFr Tiss       N   CD81 Cells; Cell; CELL MARKERS; Cellularity; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; TAPA-1; Tissue; Tissue, unspecified 2.79 2.22               %     Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
51402-6 Cells.CD81/Cells NFr CSF Pt Qn     ACTIVE CD81 cells/cells in Cerebral spinal fluid   NAM DefinitionDescription     %             CELLMARK   51402-6         Observation       0 CD81 Cells NFr CSF       N   CD81 Cells; Cell; CELL MARKERS; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; TAPA-1 2.79 2.22               %     Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
51403-4 Cells.CD81/Cells NFr Bone mar Pt Qn     ACTIVE CD81 cells/cells in Bone marrow   NAM DefinitionDescription     %             CELLMARK   51403-4         Observation       0 CD81 Cells NFr Mar       N   BM; BON; Bone marrow; CD81 Cells; Cell; CELL MARKERS; Cellularity; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; TAPA-1 2.79 2.22               %     Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
51404-2 Cells.CD81/Cells NFr Body fld Pt Qn     ACTIVE CD81 cells/cells in Body fluid   NAM DefinitionDescription     %             CELLMARK   51404-2         Observation       0 CD81 Cells NFr Fld       N   B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD81 Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; TAPA-1 2.79 2.22               %     Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
51405-9 Cells.CD81/Cells NFr Bld Pt Qn     ACTIVE CD81 cells/cells in Blood   NAM DefinitionDescription     %             CELLMARK   51405-9         Observation       0 CD81 Cells NFr Bld       N   Blood; CD81 Cells; Cell; CELL MARKERS; Cellularity; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; TAPA-1; WB; Whole blood 2.79 2.22               %     Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
51406-7 Immunoglobulin light chains.free MRat Urine 24H Qn     ACTIVE Immunoglobulin light chains.free [Mass/time] in 24 hour Urine   MIN DefinitionDescription     g/d             CHEM   51406-7         Both       0 BJ Protein Free 24h Ur-mRate       N   1 day; 24 hours; 24HR; Bence Jones protein; BJ Protein; BJ Protein Free; BJP; Chain; Chemistry; FLC; FR; Hematology; Heme; Immune globulin; Immuno; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Mass rate; mRate; Non-protein bound; QNT; Quan; Quant; Quantitative; UA; UR; Urn 2.73 2.22               g/(24.h)       0
51407-5 Streptococcus pneumoniae capsular polysaccharide Ab.IgG MCnc Ser Pt Qn IA   ACTIVE Streptococcus pneumoniae capsular polysaccharide IgG Ab [Mass/volume] in Serum by Immunoassay   MIN DefinitionDescription     mg/L             MICRO   51407-5   IA     Both       0 S pneum CPS IgG Ser IA-mCnc       N   ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Capsule; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; QNT; Quan; Quant; Quantitative; Random; S pneum CPS; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; Streptococcus pneumoniae CPS; SUDS 2.7 2.22               mg/L     The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. 0
51408-3 Streptococcus pneumoniae capsular polysaccharide Ab.IgG2 MCnc Ser Pt Qn IA   ACTIVE Streptococcus pneumoniae capsular polysaccharide IgG2 Ab [Mass/volume] in Serum by Immunoassay   MIN DefinitionDescription     mg/L             MICRO   51408-3   IA     Both       0 S pneum CPS IgG2 Ser IA-mCnc       N   ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Capsule; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; QNT; Quan; Quant; Quantitative; Random; S pneum CPS; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; Streptococcus pneumoniae CPS; SUDS 2.7 2.22               mg/L     The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. 0
51409-1 Fosamprenavir+Ritonavir Susc Isolate Pt Ord Genotyping   ACTIVE Fosamprenavir+Ritonavir [Susceptibility] by Genotype method   MIN DefinitionDescription                   ABXBACT   51409-1   Genotyping     Both       0 Fosamprenavir+Ritonavir Islt Genotyp       N   908; ANTIBIOTIC SUSCEPTIBILITIES; AST; FPV; Genotype; Genotypic; GW433908; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Lexiva; Norvir; Ordinal; Point in time; QL; Qual; Qualitative; Random; RTV; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Telzir 2.73 2.22                     Corrected Scale from OrdQn to Ord because Genotyping does not produce a quantitative susceptibility result 0
5141-7 Echovirus 3 Ab Titr Ser Pt SemiQn Comp fix   ACTIVE Echovirus 3 Ab [Titer] in Serum by Complement fixation   MAJ DefinitionDescription     titer             MICRO   5141-7   Comp fix     Both       0 ECV3 Ab Titr Ser CF       Y   ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; Dilution factor; Dilution Factor (Titer); Echo; Echo virus; Echovirus type 3; ECV; ECV3; EV; ID; III; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 1               {titer}       0
104,672 results found